Alteron's small molecules target the highly toxic TDP-43 protein to treat:
  • ALS (Amyotrophic Lateral Sclerosis )
  • AD (Alzheimer's Disease)
  • FTD (Frontotemporal Dementia)
  • CF (Cystic Fibrosis)